PL2117525T3 - Zastosowanie związków 1-fenylo-3-dimetyloaminopropanu do terapii bólu neuropatycznego - Google Patents

Zastosowanie związków 1-fenylo-3-dimetyloaminopropanu do terapii bólu neuropatycznego

Info

Publication number: PL2117525T3
Authority: PL; Poland
Prior art keywords: dimethylamino; therapy; phenyl; neuropathy pain; propane compounds
Prior art date: 2007-03-12

Application number

PL08716394T

Other languages

English (en)

Inventor

Thomas Christoph

Babette-Yvonne Kögel

Elmar Friderichs

Muriel Meen

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-03-12

Filing date

2008-03-10

Publication date

2014-05-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39345501&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2117525(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-03-10 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2014-05-30 Publication of PL2117525T3 publication Critical patent/PL2117525T3/pl

Links

NMXXDRKTOJAAQS-UHFFFAOYSA-N n,n-dimethyl-3-phenylpropan-1-amine Chemical class CN(C)CCCC1=CC=CC=C1 NMXXDRKTOJAAQS-UHFFFAOYSA-N 0.000 title 1
201000001119 neuropathy Diseases 0.000 title 1
230000007823 neuropathy Effects 0.000 title 1
208000033808 peripheral neuropathy Diseases 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

PL08716394T 2007-03-12 2008-03-10 Zastosowanie związków 1-fenylo-3-dimetyloaminopropanu do terapii bólu neuropatycznego PL2117525T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102007012165A DE102007012165A1 (de)	2007-03-12	2007-03-12	Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie des Neuropathieschmerzes
EP08716394.5A EP2117525B1 (de)	2007-03-12	2008-03-10	Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie des neuropathieschmerzes
PCT/EP2008/001884 WO2008110323A1 (de)	2007-03-12	2008-03-10	Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie des neuropathieschmerzes

Publications (1)

Publication Number	Publication Date
PL2117525T3 true PL2117525T3 (pl)	2014-05-30

Family

ID=39345501

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08716394T PL2117525T3 (pl)	2007-03-12	2008-03-10	Zastosowanie związków 1-fenylo-3-dimetyloaminopropanu do terapii bólu neuropatycznego

Country Status (13)

Country	Link
US (2)	US20080269326A1 (pl)
EP (1)	EP2117525B1 (pl)
JP (5)	JP2010520907A (pl)
CA (1)	CA2680771C (pl)
CY (1)	CY1115455T1 (pl)
DE (1)	DE102007012165A1 (pl)
DK (1)	DK2117525T3 (pl)
ES (1)	ES2452830T3 (pl)
HR (1)	HRP20140280T1 (pl)
PL (1)	PL2117525T3 (pl)
PT (1)	PT2117525E (pl)
SI (1)	SI2117525T1 (pl)
WO (1)	WO2008110323A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2582366T3 (pl) *	2010-06-15	2016-04-29	Gruenenthal Gmbh	Kombinacja farmaceutyczna do leczenia bólu
ES2882010T3 (es) *	2010-07-23	2021-11-30	Gruenenthal Gmbh	Sales o cocristales de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol
WO2012051246A1 (en)	2010-10-12	2012-04-19	Ratiopharm Gmbh	Tapentadol hydrobromide and crystalline forms thereof
RS54711B1 (en) *	2011-03-04	2016-08-31	Grünenthal GmbH	PARENTERAL TAPENTADOL ADMINISTRATION
MX344473B (es)	2011-03-04	2016-12-16	Gruenenthal Gmbh	Composicion farmaceutica acuosa semisolida que contiene tapentadol.
JP2019142972A (ja) *	2011-03-04	2019-08-29	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	タペンタドールの非経口的投与
LT2680832T (lt) *	2011-03-04	2019-10-25	Gruenenthal Gmbh	Tapentadolio vandeninė farmacinė kompozicija, skirta vartoti geriant
LT2694049T (lt)	2011-04-05	2018-12-27	GrĆ¼nenthal GmbH	Tapentadolis, skirtas skausmo perėjimo į lėtinį prevencijai
PL2694050T3 (pl) *	2011-04-05	2020-03-31	Grünenthal GmbH	Tapentadol do stosowania w leczeniu bólu związanego z nerwobólami nerwu trójdzielnego
EP3272343B1 (en)	2011-04-29	2020-02-12	Grünenthal GmbH	Tapentadol for preventing and treating depression and anxiety
SI2736501T1 (en) *	2011-07-29	2018-03-30	Gruenenthal Gmbh	Intrathecal or epidural administration of 3 - ((1S, 2S) -3- (dimethylamino) -1-ethyl-2-methylpropyl) phenol
EP2617706B1 (en)	2011-07-29	2017-09-06	Anhui New Star Pharmaceutical Development Co., Ltd	Novel intermediate used for preparing tapentadol or analogues thereof
CN103159633B (zh) *	2012-07-06	2015-08-12	江苏恩华药业股份有限公司	他喷他多的制备方法及用于制备他喷他多的化合物
EP2808319A1 (en)	2013-05-31	2014-12-03	Arevipharma GmbH	3-[3-(Dimethylamino)-1-ethyl-2-methylpropyl]phenol resin complex
PT3479823T (pt)	2015-03-27	2020-09-29	Gruenenthal Gmbh	Formulação estável para administração parentérica de tapentadol
KR20190057349A (ko)	2016-09-23	2019-05-28	그뤼넨탈 게엠베하	타펜타돌의 비경구 투여용 안정한 제제
WO2018153947A1 (en)	2017-02-23	2018-08-30	Grünenthal GmbH	Tapentadol as local anesthetic

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4426245A1 (de)	1994-07-23	1996-02-22	Gruenenthal Gmbh	1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PT1562567T (pt) *	2002-11-22	2017-08-24	Gruenenthal Gmbh	Combinação de analgésicos selecionados e inibidores da cox-ii
MX2008013779A (es) *	2006-04-28	2008-11-14	Gruenenthal Gmbh	Combinacion farmaceutica que comprende 3-(3-dimetilamino-1-etil-2- metil-propil)-fenol y paracetamol.

2007
- 2007-03-12 DE DE102007012165A patent/DE102007012165A1/de not_active Withdrawn
2008
- 2008-03-10 DK DK08716394.5T patent/DK2117525T3/da active
- 2008-03-10 SI SI200831144T patent/SI2117525T1/sl unknown
- 2008-03-10 EP EP08716394.5A patent/EP2117525B1/de active Active
- 2008-03-10 JP JP2009553058A patent/JP2010520907A/ja active Pending
- 2008-03-10 WO PCT/EP2008/001884 patent/WO2008110323A1/de active Application Filing
- 2008-03-10 CA CA2680771A patent/CA2680771C/en active Active
- 2008-03-10 PT PT87163945T patent/PT2117525E/pt unknown
- 2008-03-10 PL PL08716394T patent/PL2117525T3/pl unknown
- 2008-03-10 ES ES08716394.5T patent/ES2452830T3/es active Active
- 2008-03-11 US US12/045,830 patent/US20080269326A1/en not_active Abandoned
2010
- 2010-08-04 US US12/850,208 patent/US8536130B2/en active Active
2013
- 2013-10-02 JP JP2013206992A patent/JP6081337B2/ja active Active
2014
- 2014-02-28 CY CY20141100171T patent/CY1115455T1/el unknown
- 2014-03-24 HR HRP20140280AT patent/HRP20140280T1/hr unknown
2016
- 2016-01-07 JP JP2016001448A patent/JP2016056188A/ja active Pending
2017
- 2017-11-30 JP JP2017230230A patent/JP2018030886A/ja active Pending
2019
- 2019-08-21 JP JP2019150807A patent/JP6745959B2/ja active Active

Also Published As

Publication number	Publication date
JP2019196405A (ja)	2019-11-14
EP2117525A1 (de)	2009-11-18
DK2117525T3 (da)	2014-02-03
JP6745959B2 (ja)	2020-08-26
JP6081337B2 (ja)	2017-02-15
US20100311842A1 (en)	2010-12-09
SI2117525T1 (sl)	2014-03-31
PT2117525E (pt)	2014-02-14
JP2018030886A (ja)	2018-03-01
ES2452830T3 (es)	2014-04-02
JP2013256540A (ja)	2013-12-26
JP2016056188A (ja)	2016-04-21
CY1115455T1 (el)	2017-01-04
WO2008110323A1 (de)	2008-09-18
EP2117525B1 (de)	2013-12-25
US8536130B2 (en)	2013-09-17
CA2680771C (en)	2015-11-17
HRP20140280T1 (hr)	2014-04-25
US20080269326A1 (en)	2008-10-30
DE102007012165A1 (de)	2008-09-18
JP2010520907A (ja)	2010-06-17
CA2680771A1 (en)	2008-09-18

Publication	Publication Date	Title
PT2117525E (pt)	2014-02-14	Utilização de compostos de 1-fenil-3-dimetilaminopropano para o tratamento e terapia de dores neuropáticas
HK1211889A1 (en)	2016-06-03	Therapeutic use of diaminophenothiazines
EP2211620A4 (en)	2012-06-06	THERAPEUTIC COMPOUNDS
GB0719803D0 (en)	2007-11-21	Therapeutic compounds and their use
IL200862A0 (en)	2010-05-17	3-imidazolyl-indoles for the treatment of proliferative diseases
GB0719644D0 (en)	2007-11-14	Therapeutic compounds and their use
GB0705400D0 (en)	2007-05-02	Therapeutic compounds andm their use
GB0813087D0 (en)	2008-08-27	Therapeutic compounds
GB0716532D0 (en)	2007-10-03	Therapeutic compounds
GB0724251D0 (en)	2008-02-06	Therapeutic compounds and their use
GB0722680D0 (en)	2007-12-27	Therapeutic compounds and their use
EP2164324A4 (en)	2012-01-25	THERAPEUTIC COMPOUNDS
ZA201003425B (en)	2011-04-28	5-cyano-thienopyridines for the treatment of tumors
IL213703A (en)	2016-08-31	Compounds for the treatment of pain and other diseases
GB0715790D0 (en)	2007-09-26	Drug combination for the treatment of sialorrhoea
HK1151971A1 (en)	2012-02-17	Compounds for use in the treatment of cancer
GB0822486D0 (en)	2009-01-14	Compounds for use in the treatment of pain
EP2185568A4 (en)	2010-08-11	THERAPEUTIC COMPOUNDS
EP2222689A4 (en)	2011-11-30	THERAPEUTIC AND DIAGNOSTIC COMPOUNDS
ZA201001546B (en)	2010-10-27	Isoxazole compounds for the treatment of cancer
EP2231163A4 (en)	2012-10-31	COMPOUNDS AND THEIR THERAPEUTIC USE
GB0702862D0 (en)	2007-03-28	Therapeutic compounds
GB0808690D0 (en)	2008-06-18	Therapeutic use
GB0708188D0 (en)	2007-06-06	Therapeutic compounds
GB0705517D0 (en)	2007-05-02	Therapeutic compounds and their use